<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD) is the consequence of an abnormal immune response to environmental factors in genetically susceptible hosts </plain></SENT>
<SENT sid="1" pm="."><plain>microRNAs (miRNAs) are small, 22-nucleotide, noncoding, single-stranded <z:chebi fb="40" ids="33697">RNA</z:chebi> molecules involved in the post-tran-scriptional regulation of 30% of protein-coding genes </plain></SENT>
<SENT sid="2" pm="."><plain>Differential expression of miRNAs is described in multiple autoimmune-related conditions such as <z:hpo ids='HP_0003765'>psoriasis</z:hpo>, <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, and <z:hpo ids='HP_0002099'>asthma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Recently, unique miRNA expression profiles have been described in epithelial cells of patients with active <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, Crohn's <z:mp ids='MP_0009482'>ileitis</z:mp>, and Crohn's <z:hpo ids='HP_0002583'>colitis</z:hpo>, as well as in the peripheral blood of patients with active <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>miRNA expression profiles also change in the progression from <z:mpath ids='MPATH_458'>normal</z:mpath> colonic tissue to dysplastic tissue, with unaffected tissue from IBD patients and inflamed tissue from IBD patients showing intermediate profiles </plain></SENT>
<SENT sid="5" pm="."><plain>Understanding the role of miRNAs in IBD may lead to future insights into disease pathogenesis, diagnosis, and treatment </plain></SENT>
</text></document>